Evidence map›Paper›PMID 27427859›Full record

ArticleInvestigative ophthalmology & visual science2016

CrxRdy Cat: A Large Animal Model for CRX-Associated Leber Congenital Amaurosis.

Laurence M Occelli, Nicholas M Tran, Kristina Narfström, Shiming Chen, Simon M Petersen-Jones

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Animal models for the evaluation of retinal stem cell therapies.Progress in retinal and eye research · 2025
    Review
  4. Canine and Feline Models of Inherited Retinal Diseases.Cold Spring Harbor perspectives in medicine · 2024
    Review
  5. Review
  6. Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Crx-L253X Mutation Produces Dominant Photoreceptor Defects in TVRM65 Mice.Investigative ophthalmology & visual science · 2017
    Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Laurence M OccelliSmall Animal Clinical Sciences Michigan State University, East Lansing, Michigan, United States.
Nicholas M TranOphthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States.
Kristina NarfströmDepartment of Veterinary Medicine and Surgery, University of Missouri-Columbia, Columbia, Missouri, United States.
Shiming ChenOphthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, United States.
Simon M Petersen-JonesSmall Animal Clinical Sciences Michigan State University, East Lansing, Michigan, United States.
Michigan State University · USMichigan United · USUniversity of Missouri · US

Funding

WASHINGTON UNIVERSITY CENTER VISION RESEARCHP30EY002687 · NEI · WASHINGTON UNIVERSITY · PI Philip Andrew Ruzycki · 1985 to 2026
$18.4M
Vulnerable and Resilient Cells in Retinal DegenerationR01EY012543 · NEI · WASHINGTON UNIVERSITY · PI SHIMING CHEN, Philip Raymond Williams · 2000 to 2026
$12.2M
Research Training Program in the Vision SciencesT32EY013360 · NEI · WASHINGTON UNIVERSITY · PI SHIMING CHEN, Daniel Kerschensteiner · 2000 to 2026
$5.6M
TARGETING ABERRANT RNA METABOLISM IN CRX-LINKED RETINOPATHIESR01EY025272 · NEI · WASHINGTON UNIVERSITY · PI CHEN, SHIMING · 2016 to 2018
$1.1M
NEI NIH HHS P30 EY002687NEI NIH HHS R01 EY012543NEI NIH HHS R01 EY025272NEI NIH HHS T32 EY013360
6 · The paper itself

Abstract

purposeMutations in the retinal transcription factor cone-rod homeobox (CRX) gene result in severe dominant retinopathies. A large animal model, the Rdy cat, carrying a spontaneous frameshift mutation in Crx, was reported previously. The present study aimed to further understand pathogenesis in this model by thoroughly characterizing the Rdy retina.

methodsStructural and functional changes were found in a comparison between the retinas of CrxRdy/+ kittens and those of wild-type littermates and were determined at various ages by fundus examination, electroretinography (ERG), optical coherence tomography, and histologic analyses. RNA and protein expression changes of Crx and key target genes were analyzed using quantitative reverse-transcribed PCR, Western blot analysis, and immunohistochemistry. Transcription activity of the mutant Crx was measured by a dual-luciferase transactivation assay.

resultsCrxRdy/+ kittens had no recordable cone ERGs. Rod responses were delayed in development and markedly reduced at young ages and lost by 20 weeks. Photoreceptor outer segment development was incomplete and was followed by progressive outer retinal thinning starting in the cone-rich area centralis. Expression of cone and rod Crx target genes was significantly down-regulated. The mutant Crx allele was overexpressed, leading to high levels of the mutant protein lacking transactivation activity.

conclusionsThe CrxRdy mutation exerts a dominant negative effect on wild-type Crx by overexpressing mutant protein. These findings, consistent with those of studies in a mouse model, support a conserved pathogenic mechanism for CRX frameshift mutations. The similarities between the feline eye and the human eye with the presence of a central region of high cone density makes the CrxRdy/+ cat a valuable model for preclinical testing of therapies for dominant CRX diseases.

Indexed as

AnimalsCatsDark AdaptationDisease Models, AnimalFrameshift MutationHomeodomain ProteinsLeber Congenital AmaurosisPhenotypeRetinaRetinal Cone Photoreceptor CellsSensory ThresholdsTrans-ActivatorsTranscription, Geneticcone rod homeobox proteinHomeodomain ProteinsTrans-Activators

Identifiers

PMID27427859
PMCPMC4960999
OpenAlexW2499586131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.